Citation 107117

SANTOS,AC: UYEMURA,SA: LOPES,JLC: BAZON,JN: MINGATTO,FE: CURTI,C:. (1998). EFFECT OF NATURALLY OCCURRING FLAVONOIDS ON LIPID PEROXIDATION AND MEMBRANE PERMEABILITY TRANSITION IN MITOCHONDRIA.. 24(9)

Citation Details

Title	EFFECT OF NATURALLY OCCURRING FLAVONOIDS ON LIPID PEROXIDATION AND MEMBRANE PERMEABILITY TRANSITION IN MITOCHONDRIA.
Authors	SANTOS,AC: UYEMURA,SA: LOPES,JLC: BAZON,JN: MINGATTO,FE: CURTI,C:
Year	1998
Volume	24
Issue	9

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PINOCEMBRIN	INACTIVE
2	MEMBRANE PERMEABILITY DECREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	PINOCEMBRIN	WEAK ACTIVITY
3	MEMBRANE PERMEABILITY DECREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	PINOCEMBRIN	ACTIVE
4	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PINOCEMBRIN,7-O-METHYL:	INACTIVE
5	MEMBRANE PERMEABILITY DECREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	PINOCEMBRIN,7-O-METHYL:	ACTIVE
6	MEMBRANE PERMEABILITY DECREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	PINOCEMBRIN,7-O-METHYL:	WEAK ACTIVITY
7	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PINOBANKSIN	WEAK ACTIVITY
8	MEMBRANE PERMEABILITY DECREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	PINOBANKSIN	WEAK ACTIVITY
9	MEMBRANE PERMEABILITY DECREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	PINOBANKSIN	WEAK ACTIVITY
10	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PINOBANKSIN,3-O-ACETYL:	INACTIVE
11	MEMBRANE PERMEABILITY DECREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	PINOBANKSIN,3-O-ACETYL:	WEAK ACTIVITY
12	MEMBRANE PERMEABILITY DECREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	PINOBANKSIN,3-O-ACETYL:	WEAK ACTIVITY
13	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
14	MEMBRANE PERMEABILITY DECREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
15	MEMBRANE PERMEABILITY DECREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
16	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN,3'-O-METHYL:	ACTIVE
17	MEMBRANE PERMEABILITY DECREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN,3'-O-METHYL:	INACTIVE
18	MEMBRANE PERMEABILITY DECREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN,3'-O-METHYL:	WEAK ACTIVITY
19	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN,3-3'-4'-7-TETRA-O-METHYL:	WEAK ACTIVITY
20	MEMBRANE PERMEABILITY DECREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN,3-3'-4'-7-TETRA-O-METHYL:	WEAK ACTIVITY
21	MEMBRANE PERMEABILITY DECREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN,3-3'-4'-7-TETRA-O-METHYL:	INACTIVE
22	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN,3-3'-4'-5-7-PENTA-O-METHYL:	ACTIVE
23	MEMBRANE PERMEABILITY DECREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN,3-3'-4'-5-7-PENTA-O-METHYL:	ACTIVE
24	MEMBRANE PERMEABILITY DECREASE	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN,3-3'-4'-5-7-PENTA-O-METHYL:	WEAK ACTIVITY

Citation 107117

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1